Assoc. Prof. Dr. Georgios Xanthopoulos | Decision-making and Problem-solving | Best Researcher Award

Assoc. Prof. Dr. Georgios Xanthopoulos | Decision-making and Problem-solving | Best Researcher Award

Agricultural University of Athens | Greece

Author Profile

Google Scholar 

Early Academic Pursuits

From the outset of his academic journey, Xanthopoulos Georgios demonstrated a strong inclination toward combining engineering principles with advanced scientific methods. He pursued Agricultural Engineering, a field that allowed him to integrate environmental awareness with applied technologies for sustainable agricultural practices. His intellectual curiosity led him to complete a Master’s degree in Mathematical Modeling in Modern Technologies and Economics at the National Technical University of Athens, where he sharpened his ability to apply mathematical and computational tools to real-world problems. This early focus on modeling and quantitative analysis became a defining feature of his academic and research career. He further advanced his expertise by earning a Ph.D. in Computational Fluid Mechanics in Porous Fluids in the United Kingdom, supported by a prestigious scholarship. This academic foundation not only grounded him in engineering sciences but also cultivated his expertise in mathematical simulation and fluid dynamics, skills that would later be instrumental in addressing challenges in agricultural engineering.

Professional Endeavors

Throughout his professional career, Dr. Xanthopoulos has established himself as a respected academic and researcher in the field of agricultural engineering. He has served as an Associate Professor at the Agricultural University of Athens, where he has contributed significantly to the School of Environment and Agricultural Engineering. His leadership roles include directing the Division of Farm Structures and Farm Machine Systems, a position that highlights his administrative and academic capabilities. In addition to leadership responsibilities, he has also made a lasting impact through teaching. Over the years, he has taught numerous undergraduate and postgraduate courses, spanning subjects related to crop science, agricultural technologies, and digital innovations. His teaching portfolio includes both Greek and English programs, enabling him to reach and inspire students from diverse academic and cultural backgrounds. By mentoring the next generation of agricultural engineers, he continues to bridge the gap between traditional agricultural practices and emerging technological advancements.

Contributions and Research Focus

The core of Dr. Xanthopoulos’s research lies in postharvest technologies, particularly in the handling, storage, and processing of fresh agricultural products. His work has been instrumental in developing methods to preserve quality, extend shelf life, and ensure the safety of horticultural commodities. A significant component of his research involves the creation and application of dynamic computer-based mathematical models, often referred to as Digital Twins. These models simulate complex processes such as refrigeration, freezing, and drying, providing valuable insights into the thermophysical and mechanical properties of agricultural products. Such innovative applications not only enhance understanding of product behavior under varying conditions but also contribute to sustainable food systems by reducing waste and improving efficiency. His research also explores the integration of smart infrastructures and digital technologies in agriculture, reflecting his commitment to fostering innovation in a sector that is increasingly shaped by global challenges such as climate change and food security.

Accolades and Recognition

Dr. Xanthopoulos’s work has garnered wide recognition in the academic community. His extensive publication record, with over 45 peer-reviewed journal articles and more than 75 conference presentations at national and international levels, underscores his role as a thought leader in his field. Additionally, he holds a patent, demonstrating his ability to translate research into practical, innovative solutions. His academic influence is evident from his citation record and h-index, which reflect the impact and reach of his scholarly contributions. Beyond publications, his involvement in national and European research programs highlights the trust placed in him to contribute to projects of both scientific and societal importance. These accomplishments affirm his status as a highly respected scholar whose work resonates not only within academia but also in broader agricultural and technological communities.

Impact and Influence

The impact of Dr. Xanthopoulos’s career extends beyond research outputs to practical applications that benefit agricultural practices and food systems. His contributions in developing efficient storage and preservation techniques have helped address pressing global issues such as food quality and waste reduction. Furthermore, his leadership in academic programs has nurtured professionals who are now contributing to the modernization of agriculture worldwide. His interdisciplinary approach, which combines engineering, computational modeling, and digital technologies, has broadened the horizons of agricultural research and practice. By integrating scientific rigor with practical innovation, he has influenced policy-making, industry practices, and academic discourse, thereby reinforcing the vital role of agricultural engineering in sustainable development.

Legacy and Future Contributions

Looking ahead, Dr. Xanthopoulos is poised to further strengthen his legacy as an innovator and academic leader. His ongoing work in Digital Twins and smart agricultural infrastructures positions him at the forefront of digital transformation in agriculture. As the agricultural sector increasingly turns to data-driven and technology-enabled solutions, his expertise will continue to shape advancements in food preservation, sustainable farming, and agricultural engineering education. By mentoring emerging scholars, contributing to international collaborations, and advancing interdisciplinary research, he is laying the foundation for future generations of agricultural engineers to build upon. His legacy will be marked by a blend of scientific achievement, technological innovation, and educational leadership, ensuring that his influence extends well beyond his immediate academic environment.

Notable Publications

Title: Applicability of a single-layer drying model to predict the drying rate of whole figs
Authors: G. Xanthopoulos, N. Oikonomou, G. Lambrinos
Journal: Journal of Food Engineering
Year: 2007

Title: Satellite and Proximal Sensing to Estimate the Yield and Quality of Table Grapes
Authors: E. Anastasiou, A. Balafoutis, N. Darra, V. Psiroukis, A. Biniari, …
Journal: Agriculture
Year: 2018

Title: Modified atmosphere packaging storage of green bell peppers: Quality criteria
Authors: H. Manolopoulou, G. Xanthopoulos, N. Douros, G. Lambrinos
Journal: Biosystems Engineering
Year: 2010

Title: The contribution of transpiration and respiration in water loss of perishable agricultural products: The case of pears
Authors: G.T. Xanthopoulos, C.G. Templalexis, N.P. Aleiferis, D.I. Lentzou
Journal: Biosystems Engineering
Year: 2017

Title: Mass transport analysis in perforation-mediated modified atmosphere packaging of strawberries
Authors: G. Xanthopoulos, E.D. Koronaki, A.G. Boudouvis
Journal: Journal of Food Engineering
Year: 2012

Conclusion

In summary, Xanthopoulos Georgios exemplifies the qualities of a dedicated academic, researcher, and innovator in agricultural engineering. From his early academic pursuits in mathematical modeling and fluid mechanics to his professional role as an Associate Professor and division director, he has consistently demonstrated excellence. His pioneering research on postharvest technologies, coupled with his development of computer-based models, has significantly advanced knowledge in food preservation and agricultural systems. Recognized through publications, citations, patents, and program participation, his contributions hold both academic and practical significance. As he continues to explore new horizons in digital technologies and smart infrastructure, his work will leave an enduring legacy that inspires progress in agriculture, sustainability, and scientific innovation.

Assoc. Prof. Dr. Sefa Tatar | Innovative Leadership | Innovator of the Year in Leadership Award

Assoc. Prof. Dr. Sefa Tatar | Innovative Leadership | Innovator of the Year in Leadership Award

Necmettin Erbakan University | Turkey

Author Profile

Scopus 

Early Academic Pursuits

From the outset of his medical journey, Dr. Sefa Tatar demonstrated a strong commitment to advancing his knowledge in the field of medicine, with a focus on cardiology. His foundational education at the Faculty of Medicine equipped him with rigorous scientific training and practical exposure to the complexities of human health. During this period, he developed a keen interest in cardiovascular diseases, recognizing their global prevalence and critical impact on public health. His determination to specialize further led him to pursue advanced medical training, culminating in a specialization in cardiology. His doctoral dissertation, which investigated the prognostic significance of diastolic global longitudinal strain rate in patients with heart failure, reflects his early commitment to research-driven practice. This period of study not only laid a robust theoretical foundation but also nurtured the analytical and clinical skills that would shape his later contributions to cardiology.

Professional Endeavors

Dr. Tatar’s professional career has been marked by steady progression through diverse healthcare and academic roles. He began his practice as a physician in a state hospital, where he gained invaluable firsthand experience managing patients across a spectrum of health conditions. His clinical responsibilities during this time exposed him to the challenges of delivering effective healthcare in diverse communities. Transitioning into academia as a research assistant in cardiology, he immersed himself in teaching, clinical duties, and scientific inquiry. This role honed his dual identity as both a physician and a scholar. Later, as a specialist physician in leading hospitals, he was entrusted with critical responsibilities in patient care and advanced diagnostics. These experiences enhanced his ability to integrate clinical expertise with research, ensuring evidence-based practices were at the forefront of his medical service. Currently serving as an academician in cardiology, he continues to balance patient care, teaching, and scholarly activities, positioning himself as a versatile contributor to the field.

Contributions and Research Focus

Central to Dr. Tatar’s professional identity is his dedication to advancing cardiology research. His work on diastolic global longitudinal strain rate represents a valuable contribution to understanding heart failure outcomes, an area of immense clinical importance given its association with morbidity and mortality. Through this research, he highlighted how specific echocardiographic parameters could predict mortality, rehospitalization, and hospital stay length, offering clinicians valuable insights into patient management. Beyond this, his scholarly focus has been closely tied to practical clinical challenges, ensuring that his research directly informs and improves patient care strategies. His teaching role also underscores his contributions, as he guides medical students through complex concepts in cardiology, nurturing the next generation of physicians with a blend of academic rigor and clinical wisdom.

Accolades and Recognition

Throughout his academic and professional trajectory, Dr. Tatar has earned recognition for his expertise and contributions within the cardiology community. His membership in prestigious organizations such as the Turkish Society of Cardiology, the European Society of Cardiology, and the American Society of Cardiology attests to his standing as an active participant in the global exchange of scientific knowledge. These affiliations provide him with platforms to contribute to international dialogues, collaborate with peers, and stay abreast of cutting-edge advancements in cardiovascular medicine. His inclusion in such societies reflects both his credibility as a researcher and his dedication to professional growth within the discipline.

Impact and Influence

Dr. Tatar’s impact extends across multiple spheres—clinical care, academic teaching, and scientific research. His work bridges the gap between research outcomes and bedside practice, ensuring that patients benefit from the most current evidence-based approaches. In the classroom, he influences aspiring physicians by instilling in them the importance of critical thinking and scientific inquiry, shaping future professionals who will carry forward his ethos of combining compassion with precision. Within the research community, his focus on predictive markers in heart failure adds to the growing body of knowledge that informs treatment protocols and healthcare policies. Collectively, these contributions highlight his role as a thought leader and mentor within cardiology.

Legacy and Future Contributions

Looking ahead, Dr. Tatar’s trajectory suggests a continued commitment to advancing cardiology through both research and practice. His academic career provides a strong platform for producing innovative studies that address unresolved challenges in cardiovascular medicine. With his grounding in both clinical practice and scientific research, he is poised to contribute to new diagnostic tools, prognostic models, and therapeutic strategies that can transform patient outcomes. Additionally, his dedication to teaching ensures that his legacy will be carried forward by students and colleagues who benefit from his mentorship. His future contributions are likely to resonate not only within his immediate professional circles but also across the broader global cardiology community, where innovative approaches to patient care and disease management are urgently needed.

Notable Publications

Association of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency

Authors: Not listed in your excerpt
Journal: BMC Immunology
Year: 2025

Diastolic global longitudinal strain and acute ischemic stroke: a hidden relationship?

Authors: Not listed in your excerpt
Journal: BMC Cardiovascular Disorders
Year: 2025

Conclusion

Dr. Sefa Tatar’s journey reflects the seamless integration of academic excellence, clinical expertise, and research innovation. From his early academic pursuits through his professional endeavors in healthcare institutions and academia, he has consistently demonstrated a deep commitment to advancing cardiology. His research contributions, professional recognition, and influence on both students and patients underscore his significance in the field. With a strong foundation and clear vision for the future, his work promises to leave a lasting legacy in cardiovascular medicine while shaping future directions in research, teaching, and clinical practice.

Assist Prof Dr. Taku Ishii | Decision-making and Problem-solving | Best Research Article Award

Assist Prof Dr. Taku Ishii | Decision-making and Problem-solving | Best Research Article Awar

Institute of Science Tokyo | Japan

Author Profile

ORCID

Early Academic Pursuits

Taku Ishii’s academic path reflects a focused dedication to understanding and addressing complex pediatric cardiovascular diseases. From the outset of his medical education, he was drawn to the intricacies of pediatric cardiology, a specialty that demands both technical precision and a deep sense of compassion. His early clinical training allowed him to develop expertise in diagnosing and managing congenital heart disease and pulmonary hypertension, conditions that profoundly affect the lives of young patients and their families. Seeking to enhance his approach to patient care, he pursued graduate studies in public health, which broadened his perspective beyond individual treatment toward the systemic and epidemiological aspects of healthcare. This unique combination of clinical and public health training equipped him with a multifaceted approach to pediatric cardiology, enabling him to address not only the biological mechanisms of disease but also the societal factors influencing patient outcomes.

Professional Endeavors

In his current role as an Assistant Professor at the Institute of Science Tokyo, Taku Ishii operates at the intersection of clinical practice, academic instruction, and research leadership. As a clinician, he provides specialized care to children with life-threatening and complex cardiac conditions, applying innovative treatment strategies to improve long-term health outcomes. His academic contributions involve mentoring medical students and residents, fostering their clinical judgment, technical skills, and dedication to compassionate care. Beyond the classroom and hospital, he actively participates in the Japanese Association of Congenital Heart Disease with Pulmonary Hypertension (JACPHR), contributing to collaborative research and nationwide efforts to advance understanding and management of these conditions. His professional life is characterized by a commitment to advancing patient care while building the capacity of the next generation of pediatric cardiologists.

Contributions and Research Focus

Taku Ishii’s research portfolio reflects his dual commitment to scientific advancement and clinical relevance. His studies encompass molecular biology, clinical cardiology, and epidemiology, creating a holistic body of work that addresses both the mechanisms and management of pediatric heart diseases. His co-authored research in The FASEB Journal explores the role of Hedgehog signaling in the development of pulmonary arterial hypertension, identifying cyclopamine as a potential therapeutic agent to mitigate disease progression. His work published in Cureus examines the role of implantable cardioverter defibrillators in preventing sudden cardiac death in children with arrhythmogenic right ventricular cardiomyopathy, providing much-needed data to guide treatment in pediatric populations. Additionally, his collaboration in the Journal of Human Genetics documents novel cases of HYAL2 deficiency, linking genetic variations to different clinical severities, and reinforcing the integration of genetic insights into pediatric cardiology. Through these contributions, he advances both the understanding of disease mechanisms and the development of patient-centered therapeutic strategies.

Accolades and Recognition

Taku Ishii’s achievements have earned him professional recognition within both national and international medical communities. His appointment as an assistant professor at the Institute of Science Tokyo underscores his standing as a respected academic and clinician. His publications in high-impact, peer-reviewed journals demonstrate the scientific rigor and clinical relevance of his work, contributing to ongoing global conversations in pediatric cardiology. His active involvement in collaborative research networks, such as the JACPHR, not only highlights his commitment to team-based science but also positions him as a valued contributor to the advancement of pediatric cardiac care. These acknowledgments reflect the trust placed in his expertise and his role in influencing the future direction of his field.

Impact and Influence

The influence of Taku Ishii’s work is evident in both direct patient care and the broader advancement of pediatric cardiology. Clinically, his interventions have improved the lives of children with complex and often life-threatening cardiac conditions. Academically, his teaching and mentorship shape the perspectives and capabilities of emerging pediatric specialists, instilling in them the values of precision, empathy, and evidence-based practice. His research, grounded in both clinical and public health perspectives, informs treatment guidelines and contributes to national health strategies aimed at better managing pediatric cardiovascular diseases. By bridging molecular research with patient care and policy considerations, he has established himself as a central figure in ensuring that scientific advances translate into tangible improvements in health outcomes.

Legacy and Future Contributions

Looking ahead, Taku Ishii is well-positioned to continue driving innovation in pediatric cardiology through cutting-edge research and collaborative initiatives. His ongoing studies in pulmonary hypertension and congenital heart disease have the potential to yield new diagnostic tools and therapeutic approaches, ultimately improving survival rates and quality of life for affected children. His interest in genetic research is likely to further integrate precision medicine into pediatric care, paving the way for individualized treatment strategies. Equally important is his role as an educator and mentor, ensuring that his knowledge and values are passed on to future generations of physicians and researchers. His legacy will be defined by both his scientific contributions and his enduring influence on the medical professionals he has trained and inspired.

Notable Publications

Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)

Authors: Taku Ishii; Keiko Uchida; Susumu Hosokawa; Reina Ishizaki; Naofumi F Sumitomo; Yoshiyuki Furutani; Hidekazu Ishida; Shinichi Takatsuki; Kei Inai; Kunihiko Takahashi et al.
Journal: The American Journal of Cardiology
Year: 2025

Marked improvement in severe pulmonary arterial hypertension following airway infection in a patient with a heterozygous BMP9 nonsense mutation: A case report

Authors: Taku Ishii; Makito Sakurai; Yohei Yamaguchi; Kei Takasawa; Susumu Hosokawa
Journal: — (Other publication type)
Year: 2025

Challenges in Accurately Assessing Acute Vasoreactivity in Pediatric Pulmonary Arterial Hypertension: Case Reports Highlighting the Impact of Sedation on Diagnostic Accuracy

Authors: Kana Inoue; Taku Ishii; Yohei Yamaguchi; Satoshi Nagahara; Makito Sakurai; Susumu Hosokawa; Shozaburo Doi; Diego Araiza-Garaygordobil
Journal: European Heart Journal – Case Reports
Year: 2025

Exploring viral infections’ role in Kawasaki disease onset: A study during the COVID‐19 pandemic

Authors: Taku Ishii; Nobutoshi Nawa; Susumu Hosokawa; Tomohiro Morio; Takeo Fujiwara
Journal: Journal of Medical Virology
Year: 2024

Association between the initiation of insurance coverage for fetal echocardiography and mortality from congenital heart disease in infants: An interrupted time series analysis

Authors: Taku Ishii; Nobutoshi Nawa; Shozaburo Doi; Tomohiro Morio; Takeo Fujiwara
Journal: Paediatric and Perinatal Epidemiology
Year: 2023

Conclusion

Taku Ishii’s career embodies the integration of clinical excellence, academic leadership, and research innovation. His journey from focused academic preparation to impactful professional practice demonstrates a sustained commitment to improving the lives of children with complex cardiac conditions. Through his clinical care, he offers hope and healing to patients and families; through his research, he advances the understanding and treatment of pediatric heart diseases; and through his mentorship, he shapes the future of the field. His work stands as a testament to the power of combining science, compassion, and education to create meaningful and lasting change in medicine.

Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

National Taipei University of Nursing and Health Sciences, Taiwan

Author Profile

Scopus

🎓 Early Academic Pursuits

Professor Kuan-Chen Chen embarked on his academic journey with a profound interest in the intricate dynamics of finance and its intersection with health care systems. He earned his Ph.D. in Finance from National Chengchi University, one of Taiwan’s most prestigious institutions known for excellence in business and social sciences. During his doctoral studies, Professor Chen exhibited a keen aptitude for analytical reasoning, quantitative modeling, and an interest in macro and micro-level financial systems. This formative academic experience laid the foundation for a career that would eventually bridge the worlds of finance and healthcare management—a rare and essential confluence in today’s complex health economies.

His early academic work reflected a deep engagement with both theoretical models and empirical data, which allowed him to develop a nuanced understanding of how financial principles could be applied to optimize healthcare operations. These academic roots inspired him to explore the evolving financial challenges of healthcare institutions and to delve into research that could influence not only academic scholarship but also real-world practices.

💼 Professional Endeavors

Currently a Professor in the Department of Health Care Management at the National Taipei University of Nursing and Health Sciences (NTUNHS), Professor Chen brings years of academic rigor and practical insight into the classroom and research laboratory. At NTUNHS, he is deeply involved in teaching, research, and academic leadership, offering specialized courses such as financial management, healthcare management, and hospital performance evaluation. These courses are designed not only to impart knowledge but to cultivate critical thinking among future healthcare managers and policymakers.

In parallel with his academic role, Professor Chen has successfully led multiple government-funded research projects, showcasing his ability to secure competitive grants and apply findings to public policy and institutional reforms. He maintains close ties with the healthcare industry, acting as a collaborative partner and advisor, which reinforces the relevance and applicability of his research.

🔬 Contributions and Research Focus

Professor Chen’s research portfolio reflects a rich blend of finance, healthcare systems, and policy evaluation. His scholarly work has notably explored working capital management, agency costs, economies of scope, and corporate social responsibility (CSR) within hospital settings.

One of his notable research projects, funded by Taiwan’s National Science Council, titled “The Impact of Working Capital Management on Financial Performance: Empirical Evidence from Hospitals in Taiwan”, addressed critical concerns surrounding liquidity and resource allocation in healthcare institutions. By empirically assessing how hospitals manage their short-term financial assets and liabilities, this study provided strategic insights into improving financial efficiency and service delivery.

Another significant project, “Agency Costs, Economies of Scope, and Corporate Social Responsibility in Hospitals,” reflects his forward-thinking approach toward integrating CSR into the operational fabric of healthcare organizations. This research explores how broader social objectives can coexist with fiscal accountability and institutional efficiency.

His citation metrics further affirm his scholarly influence:

  • Total Citations: 506

  • Citations since 2020: 309

  • h-index: 13 (10 since 2020)

  • i10-index: 15 (12 since 2020)

These figures highlight the continued relevance and reach of his research across academic and policy-making communities.

🏅 Accolades and Recognition

While Professor Chen’s career is marked by impactful research and educational contributions, he has also received recognition for his academic leadership and policy relevance. Being entrusted with multiple government-backed projects is a testament to his credibility and the confidence that both academia and public institutions place in his expertise. His role as a principal investigator in projects that examine the financial underpinnings of Taiwan’s hospital system has further established him as a thought leader in health finance.

Moreover, his active engagement with the healthcare industry reflects not just theoretical depth but also practical understanding—an invaluable combination that places him in demand as a consultant, advisor, and speaker.

🌍 Impact and Influence

Professor Chen’s work resonates not just within Taiwan but also has implications for the global discourse on healthcare economics and management. By addressing the dual imperatives of financial sustainability and quality patient care, his research contributes to international conversations on how healthcare systems can navigate the challenges of limited resources, aging populations, and rising costs.

His insights into CSR in hospitals underscore the evolving expectations of healthcare institutions—not merely as providers of clinical services but as socially responsible entities accountable to a wider array of stakeholders, including communities, regulators, and investors.

Through teaching and mentorship, Professor Chen has also cultivated a new generation of scholars and practitioners, many of whom go on to apply his models and methods in diverse institutional settings, thereby multiplying the reach of his impact.

🔮 Legacy and Future Contributions

As a respected academic and a prolific researcher, Professor Kuan-Chen Chen is poised to continue his influential work at the nexus of healthcare and financial management. His future research is likely to further explore the digital transformation of healthcare finance, value-based care models, and the role of data analytics in improving hospital performance.

With Taiwan and other nations grappling with health financing reforms, Professor Chen’s work will undoubtedly remain central to shaping policy decisions and institutional strategies. His balanced approach—grounded in rigorous analysis yet attentive to real-world application—ensures that his legacy will not only be scholarly but also deeply practical and socially relevant.

Looking ahead, he is set to expand his collaborations, possibly leading cross-national studies, and contributing to global best practices in hospital financial governance. His journey exemplifies how academic excellence, when combined with a sense of purpose, can leave an enduring imprint on both institutions and society at large. 🌟

📝Notable Publications

Healthcare utilization and costs for patients with Parkinson’s disease in Taiwan

Authors: Kuan-Chen Chen, Li-Jung Elizabeth Ku, Ya-Hui Hu, Yu Sun, Alexis Elbaz, Pei-Chen Lee

Journal: BMC Neurology

Year: 2025

Assoc. Prof. Dr. Junpeng Ma | Team Building and Team Management | Best Researcher Award

Assoc. Prof. Dr. Junpeng Ma | Team Building and Team Management | Best Researcher Award

sichuan university, China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Junpeng Ma began his academic journey in the field of electrical engineering at Southwest Jiaotong University in Chengdu, China. His intellectual curiosity and deep interest in energy systems quickly distinguished him among his peers. He completed his Bachelor of Science (B.S.) degree in 2013, laying a strong foundation in electrical circuits, power electronics, and systems engineering. Fueled by a desire to contribute to the rapidly evolving energy sector, he continued his academic pursuit at the same institution, earning his Ph.D. in 2018. During his doctoral studies, Dr. Ma focused on the intricate dynamics of modern energy systems, with particular attention to renewable energy integration and high-voltage transmission.

In a pivotal phase of his academic development, Dr. Ma expanded his horizons internationally by joining Aalborg University in Denmark as a Guest Ph.D. Student from November 2017 to May 2018. Aalborg is renowned for its excellence in power electronics and smart energy systems, and this experience gave Dr. Ma access to advanced methodologies and a global network of researchers. It not only sharpened his technical acumen but also enriched his cultural and collaborative skills—traits that would become central to his later work as an educator and innovator.

👨‍🏫 Professional Endeavors

Upon completion of his doctoral degree, Dr. Ma began his professional academic career at Sichuan University, one of China’s most prestigious institutions. He now serves as an Associate Professor in the College of Electrical Engineering, where he combines his passion for teaching with a deep commitment to cutting-edge research. In this role, he has been instrumental in educating future engineers and leading advanced research initiatives in energy systems.

Dr. Ma’s professional focus encompasses both classroom instruction and the development of research projects that address national and global energy challenges. He is actively engaged in supervising graduate students, designing curricula in line with the latest technological trends, and publishing research that informs the design and optimization of power grids. His position enables him to contribute to Sichuan University’s growing reputation in power system innovation while continuing his own journey of academic excellence.

🔬 Contributions and Research Focus

Dr. Ma’s research centers on two of the most critical elements of modern energy infrastructure: the modeling and control of new energy clusters and high-voltage direct current (HVDC) systems. As global energy networks pivot toward renewable sources, the challenge of managing their intermittent and decentralized nature has come to the forefront. Dr. Ma’s work addresses these challenges through advanced modeling techniques and control strategies designed to improve reliability and efficiency.

New energy clusters often integrate wind, solar, battery storage, and other distributed energy resources. Dr. Ma develops frameworks that allow these systems to function cohesively under changing environmental and load conditions. In parallel, his research on HVDC systems—which are essential for long-distance power transmission—focuses on optimizing their operation to reduce losses, manage faults, and enable more flexible energy exchange between regions. His contributions in these areas are instrumental in supporting China’s—and the world’s—transition to a low-carbon energy future.

🏆 Accolades and Recognition

Dr. Ma’s dedication to impactful research has been recognized through a series of prestigious awards from major scientific and professional bodies. He was awarded the Second Prize of the Science and Technology Progress Award by the China Electrotechnical Society, where he was recognized as the leading contributor (1st out of 10). This accolade reflects the technical depth and relevance of his work in the field of power systems.

He also received the First Prize of the Science and Technology Progress Award from the China Association of Work Safety (2nd out of 15), honoring his contributions to the safety and reliability of energy infrastructure—an area of increasing importance in the era of energy transition. Additionally, he was honored with the Second Prize of the Science and Technology Progress Award of Sichuan Province (3rd out of 8), further affirming his regional influence and scientific merit. These awards underscore his ability to translate complex research into practical innovations that benefit both industry and society.

🌍 Impact and Influence

Beyond his academic achievements, Dr. Ma’s work exerts a significant influence on the practical development of smart and sustainable energy systems. His research findings are routinely cited and applied in projects focused on grid modernization and renewable integration. In China’s ambitious move toward energy decarbonization, his contributions support essential initiatives aimed at improving grid flexibility, enhancing power quality, and ensuring energy security.

As an educator, Dr. Ma plays a transformative role in shaping the minds and careers of young engineers. His students are not only equipped with technical skills but are also inspired by his example of research-driven societal contribution. His influence extends beyond the university, as he participates in technical committees, delivers lectures at academic conferences, and collaborates with research institutes and industry partners across China and internationally.

🔮 Legacy and Future Contributions

Looking forward, Dr. Junpeng Ma is positioned to be a thought leader and innovator in the global transition toward intelligent, decarbonized energy systems. His continued research promises to yield further breakthroughs in the areas of renewable energy management, smart grid resilience, and advanced control systems for HVDC technologies. These advancements will not only shape technical practices but also inform policy-making and investment in sustainable energy infrastructure.

His legacy will likely be defined by a combination of academic rigor, technological innovation, and societal impact. As he mentors future researchers and deepens his contributions to global energy solutions, Dr. Ma stands as a vital figure in the evolution of electrical engineering in the 21st century. His work today lays the groundwork for a cleaner, smarter, and more resilient energy future for all.

📝Notable Publications

Prediction Method and Optimal Control of Subsequent Commutation Failure in LCC-HVDC System Based on Dynamic Extinction Angle Equation

Author(s): Zhiwei Lei, Junpeng Ma, Shunliang Wang, Ning Jiao, Tianqi Liu
Journal: Dianli Xitong Baohu yu Kongzhi / Power System Protection and Control
Year: 2025

Stability Analysis of Power Self-Synchronization Control of Grid-Forming Converters in Wide Range of Short-Circuit Ratio Conditions

Author(s): Junpeng Ma, Lei Li, Chengbin Chi, Shunliang Wang, Tianqi Liu
Journal: Dianli Xitong Baohu yu Kongzhi / Power System Protection and Control
Year: 2025

Adaptive Control Strategy of Disturbance Voltage for Impedance Measurement

Author(s): Jingbo Zhao, Qian Zhou, Wenli Yang, Junpeng Ma
Journal: Journal of Power Supply
Year: 2025

A Thyristor-Based Solid-State DC Circuit Breaker With a Three-Winding Coupled Inductor

Author(s): Shunliang Wang, Ming Li, Kejun Qin, Nie Hou, Tianqi Liu
Journal: IEEE Transactions on Power Electronics
Year: 2025

 An Asymmetric Hybrid Phase-Leg Modular Multilevel Converter With Small Volume, Low Cost, and DC Fault-Blocking Capability

Author(s): Rui Zhang, Shunliang Wang, Junpeng Ma, Tianqi Liu, Yun Yang
Journal: IEEE Transactions on Power Electronics
Year: 2025

Dr. Yang Xu | Strategic Leadership | Best Researcher Award

Dr. Yang Xu | Strategic Leadership | Best Researcher Award

Hubei Medical Devices Quality Supervision and Test Institute, China

Author Profile

Scopus 

🎓 Early Academic Pursuits

Yang Xu’s journey into the world of engineering and medical device innovation began with a strong academic foundation rooted in applied sciences and engineering principles. Driven by a curiosity about the intersection of technology and human health, Yang pursued rigorous technical education, laying the groundwork for a future in biomedical engineering. From his early academic days, Yang exhibited a meticulous approach to problem-solving and a keen interest in the complex dynamics of electronic systems and their applications in healthcare. This led to his early involvement in research projects focused on the safety and performance of active medical devices—especially ultrasonic surgical instruments.

Throughout his formative academic years, Yang Xu demonstrated a strong aptitude for both theoretical understanding and practical application. This dual capability equipped him with the technical insight required to navigate the multidisciplinary demands of the medical device field. His early work often bridged the gap between laboratory research and clinical application, which would later become a hallmark of his professional contributions.

🛠️ Professional Endeavors

Yang Xu currently serves as the Dean of the Hubei Medical Devices Quality Supervision and Test Institute, a prestigious role that underscores his leadership in the field of medical device quality and safety. His concurrent position as the Director of the NMPA Key Laboratory for Quality Evaluation of Ultrasonic Surgical Instruments further highlights his specialization in the performance assessment of high-precision surgical technologies.

His extensive career encompasses pivotal roles such as IEC/CISPR Registered Expert, CNAS Assessor, and CMA Expert Reviewer. These positions are a testament to his credibility and technical authority in standards development and compliance. Within the framework of China’s standardization efforts, Yang has made impactful contributions as a member of SAC/TC79/SC2 and SAC/TC246/SC2, where he focuses on radio interference and electromagnetic compatibility (EMC) in industrial and medical devices.

Yang’s leadership extends to influential national platforms. He serves on the Executive Committee of the NMPA Technical Committee on Medical Device Classification and holds a key role in the CISPR/B/WG7, which deals with international EMC standardization for information technology equipment. His engagement with the National Engineering Research Center for Ultrasonic Medicine and as a Clinical Master Co-supervisor at the State Key Lab of Ultrasound in Medicine and Engineering signifies his active involvement in guiding young researchers and engineers.

🔬 Contributions and Research Focus

Yang Xu has long been engaged in technical operations related to the inspection, testing, standardization, quality control, and safety evaluation of active medical devices. His expertise particularly centers on electromagnetic compatibility (EMC) and the clinical performance of ultrasonic surgical tools. These contributions have elevated China’s capability to ensure the safety and reliability of emerging medical technologies.

He has played a leading role in three National Key R&D Programs, showcasing his capacity to steer complex, high-impact research projects. Additionally, Yang has contributed to one international standard and eight national standards, reflecting his active involvement in shaping the regulatory landscape of medical devices both in China and internationally.

His academic output includes 37 published papers and contributions to several technical monographs, making him a respected voice in both engineering circles and academic forums.

🏅 Accolades and Recognition

Yang Xu’s achievements have earned him widespread recognition across regulatory, academic, and professional communities. His position as a registered expert and assessor with key institutions like CNAS and CMA underscores the trust placed in his technical judgment. His membership in committees across national and international bodies attests to his authority and leadership in standardization and quality evaluation.

His role in drafting national and international standards has been particularly impactful, helping bridge the gap between local regulatory practices and global compliance expectations. Such efforts are often recognized as instrumental in promoting China’s presence in the global medical device quality assurance ecosystem.

🌍 Impact and Influence

Through his leadership at the Hubei Medical Devices Institute and various technical committees, Yang Xu has significantly influenced policy-making, quality assurance systems, and the development of performance benchmarks for active medical devices. His work ensures that patients receive safe, effective, and reliable care through rigorously tested and standardized medical technologies.

Moreover, Yang’s role in mentoring young professionals—particularly through his co-supervisory position—has cultivated a new generation of biomedical engineers and clinical researchers who continue to expand on his legacy. His multidisciplinary approach, which combines engineering, clinical validation, and regulatory knowledge, serves as a model for holistic innovation in medical technology.

🌟 Legacy and Future Contributions

Yang Xu’s contributions form a legacy of scientific rigor, regulatory advancement, and clinical relevance. His work has enhanced the performance and safety of ultrasonic surgical instruments, contributed to international standardization efforts, and strengthened China’s medical device evaluation infrastructure.

Looking forward, Yang is poised to continue influencing emerging fields like AI-integrated medical devices, minimally invasive ultrasonic surgery, and real-time EMC diagnostics. His ongoing involvement in key research programs and regulatory bodies ensures that his insights will shape the future of healthcare technology in China and beyond.

As a leader, researcher, and mentor, Yang Xu’s dedication to innovation and safety in medical devices stands as a beacon of excellence—setting a high standard for future engineers and scientists in the field. 🚀

📝Notable Publications

An Algorithm of mmWave MIMO Antenna Exposure Based on Unsupervised Deep Learning

👨‍💼 Authors:  Yang Xu, Haitao Fu, Yawen Liu, Xiong Hui

📘 Journal/Conference: Proceedings of the 7th International Conference on Information Science, Computer Technology and Transportation (ISCTT 2022)

📅 Year: 2022

Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Capital Center for Children’s Health, Capital Medical University, China

Author Profile

Orcid

🌱 Early Academic Pursuits

Jia Liu began her academic journey with a strong focus on medical sciences, where she pursued an M.D. in Otolaryngology Head and Neck Surgery from Beijing Anzhen Hospital, affiliated with Capital Medical University, between 2013 and 2016. Her dedication to expanding her medical expertise led her to the University of Chicago, USA, in 2015, where she gained invaluable experience as a visiting student. This international exposure enriched her understanding of advanced clinical practices and set the stage for her future career.

💼 Professional Endeavors

After completing her academic training, Jia Liu began her professional career as a resident at Beijing Anzhen Hospital from 2016 to 2019. Here, she honed her clinical skills in otolaryngology, particularly in the diagnosis and treatment of head and neck disorders. Her dedication and growing expertise earned her a position as an attending physician at the Capital Center for Children’s Health, Capital Medical University, in 2019. In this role, she has continued to provide high-quality care while also actively engaging in research, making significant contributions to pediatric otolaryngology.

🔬 Contributions and Research Focus

Jia Liu’s research is distinguished by its focus on otolaryngology, with a particular emphasis on olfactory disorders. Her notable project, funded by the Beijing Natural Science Foundation from 2019 to 2020, focused on the “Pedigree study on the molecular mapping, screening, and expression of olfactory genes for isolated congenital anosmia.” This research has advanced the understanding of the genetic basis of olfactory disorders, paving the way for improved diagnostic methods and therapeutic strategies.

🏆 Accolades and Recognition

Jia Liu’s dedication and achievements have been recognized through several prestigious awards. In 2014, she received the “Merck Clinical Scholar Award” from the American Academy of Otolaryngic Allergy (AAOA), a recognition of her early potential in the field. The following year, she was awarded a Chinese Government Scholarship from the China Scholarship Council, enabling her to study abroad at the University of Chicago. Her exceptional contributions to medical science were further acknowledged with the Beijing Medical Science and Technology Prize in 2018 and the Chinese Medical Science and Technology Prize in 2019.

🌐 Impact and Influence

Jia Liu has significantly impacted the field of otolaryngology, especially in pediatric care. Her clinical expertise and commitment to research have established her as a respected figure in her field. Her work in understanding and treating olfactory disorders has not only advanced scientific knowledge but has also improved clinical practices.

🌟 Legacy and Future Contributions

Jia Liu is poised to continue making significant contributions to otolaryngology. Her commitment to exploring the genetic basis of olfactory disorders positions her to lead future breakthroughs in the diagnosis and treatment of these conditions. As she continues her work at the Capital Center for Children’s Health, her legacy as a dedicated clinician and researcher is set to grow.

📝Notable Publications

Evaluation of brain and neurophysiologic function in isolated congenital anosmia

Author(s): Liu J, Gao X, Zhan X, Lu Y, Yao L, Yi X, Gu Q
Journal: American Journal of Otolaryngology
Year: 2025

 The effect of nasopharyngeal obstruction on the olfactory bulb volume and olfactory sulcus depth in children

Author(s): Yao L, Liu J, Xiaoli Yi, Gu Q
Journal: European Archives of Oto-Rhino-Laryngology
Year: 2024

 Analysis of clinical characteristics in the patient with olfactory disorders

Author(s): Liu J, Zhan X, Yao L, Xie H, Chang F
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Prognostic value of olfactory bulb volume in patients with post-viral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Predictors of posttreatment olfactory improvement in patients with postviral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2021

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Shanghai AZ Science and Technology Co., Ltd.

Author Profile

Orchid

🌱 Early Academic Pursuits

From the very beginning of his academic journey, Dr. Youmin Zhu demonstrated an exceptional passion for biological sciences. His intellectual curiosity led him to pursue a Ph.D. in biological sciences, where he laid a solid foundation in molecular biology, biotechnology, and pharmacology. During his doctoral years, he cultivated a deep interest in cutting-edge therapeutic strategies, particularly focusing on emerging protein degradation technologies and the role of bioactive peptides. His academic rigor and scientific curiosity propelled him to explore innovative modalities that bridged traditional research with real-world applications in drug and skincare development. These formative experiences not only enriched his technical skills but also instilled a vision to contribute meaningfully to both science and society.

🧪 Professional Endeavors

Now serving as the R&D President and Chief Scientist at Shanghai AZ Science and Technology Co., Ltd., Dr. Zhu has emerged as a visionary leader in the field of biotechnology. Under his guidance, the organization has completed over 20 major R&D projects, encompassing the development of peptide PROTACs-based skincare ingredients, enzymes, and probiotics. These endeavors reflect not only his scientific expertise but also his ability to translate theoretical concepts into commercial and therapeutic innovations.

Dr. Zhu’s strategic direction in the biotechnology sector has turned his company into a powerhouse of innovation, where the fusion of peptide-based therapeutics and skincare science is leading to transformative solutions. His work has bridged academic excellence with industrial application, enabling breakthroughs in precision medicine and advanced cosmeceuticals.

🔬 Contributions and Research Focus

Dr. Zhu’s research focus lies at the intersection of molecular biology, pharmacological innovation, and cosmetic science, with a central emphasis on peptide PROTACs (Proteolysis Targeting Chimeras). His pioneering efforts in this area have highlighted the multi-targeting potential of peptides, their biodegradability, low toxicity, and modular design, all of which present significant advantages over conventional small molecules and antibodies.

One of his most notable contributions is the publication of the article titled “The Peptide PROTAC Modality: A New Strategy for Drug Discovery” in MedComm (2025), an SCI-indexed journal with an impressive impact factor of 10.7. This work has been widely recognized in the scientific community and is already making waves in discussions around next-generation therapeutic strategies. The article has been cited across multiple domains, further demonstrating its relevance and value in ongoing pharmaceutical research.

With a total of over 10 scientific publications, Dr. Zhu has consistently contributed to scholarly literature and advanced dialogue in biotherapeutics. In addition, he holds 18 authorized patents in China, such as Patent No. CN202410445356.X, further underscoring his commitment to translating innovation into intellectual property and practical applications.

🏆 Accolades and Recognition

Dr. Zhu’s groundbreaking work has not gone unnoticed. His scientific and entrepreneurial achievements have earned him recognition within academic, industrial, and international circles. In addition to being a contributing scientist to impactful research, he has also been actively involved in collaborative projects with prestigious institutions including Fudan University, Shanghai Jiao Tong University, and Zhejiang University.

He is also an esteemed member of professional networks such as the Chinese Overseas Alliance and the Chinese Doctoral Alliance, where he continues to contribute to thought leadership and global knowledge exchange.

Furthermore, his work was recently highlighted in a widely circulated WeChat feature and an official PDF document of professional certification, showcasing his influence in both academic and industrial spheres.

🌍 Impact and Influence

Dr. Zhu’s influence extends beyond scientific circles. His work on peptide PROTACs is helping redefine how we understand and treat complex diseases. By leveraging the natural degradation mechanisms of the body through targeted proteolysis, his innovations are creating new avenues for the treatment of conditions previously considered untreatable.

Equally impressive is his impact on precision skincare, where bioengineered peptide-based compounds are providing customized, low-toxicity solutions for skin health. This cross-disciplinary impact, from health to beauty, positions Dr. Zhu as a transformative figure in the biotech and wellness industries.

His articles, particularly those involving collaborative authorship with Yu Dai and Yuncai Tian, have sparked global interest, and the citation of his MedComm article continues to grow. These ripple effects reflect the profound scientific and commercial value of his work.

🌟 Legacy and Future Contributions

As Dr. Zhu continues to push boundaries, the future of peptide-based therapeutics and cosmeceuticals looks increasingly promising. He is paving the way for a new era of precision medicine, where treatments are not only more effective but also safer and more sustainable.

Looking ahead, Dr. Zhu plans to scale his innovations globally and expand his company’s reach into international markets, bringing Chinese biotechnology to the global stage. His future goals include mentoring young scientists, fostering new academic-industry partnerships, and developing a global research ecosystem centered on peptide technologies.

Through his unwavering dedication and strategic foresight, Dr. Youmin Zhu is building a legacy that will inspire a generation of researchers and innovators. His contributions are not only advancing science but also shaping the future of healthcare and skincare for the better. 🌐

The Peptide PROTAC Modality: A New Strategy for Drug Discovery

Authors: Youmin Zhu, Yu Dai, Yuncai Tian
Journal: MedComm
Year: 2025

New Nobel Prize MicroRNA Technology Is Opening up a New Era of Precision Skincare

Authors: Youmin Zhu, Yu Dai, Xiaojing Wang, Shengjie Zhu, Yuncai Tian, Yong Tian
Journal: Advanced Journal of Nursing
Year: 2025

New peptide PROTAC is triggering a revolution in precise targeted skincare

Authors: Youmin Zhu, Yu Dai, Yuncai Tian, Yong Tian
Journal: Preprint (platform not specified)
Year: 2024

Advances in CRISPR/Cas9

Authors: Youmin Zhu, Syed Hassan
Journal: BioMed Research International
Year: 2022

Comparative Transcriptomics Reveals Jasmonic Acid-Associated Metabolism Related to Cotton Fiber Initiation

Authors: Liman Wang, Youmin Zhu, Wenjing Hu, Xueying Zhang, Caiping Cai, Wangzhen Guo
Journal: PLOS ONE
Year: 2015

Mr. Asahi Matsubara | leadership | Best Researcher Award |3637

Mr. Asahi Matsubara | leadership | Best Researcher Award

Graduate school of Nippon Sport Science University, Japan

Author Profile

Orchid 

🌱 Early Academic Pursuits

Asahi Matsubara’s journey into academia and research began with a deep curiosity about human potential and a strong passion for sport psychology. From the earliest days of higher education, Asahi displayed a distinct interest in understanding the psychological intricacies that shape athletic performance and team dynamics. This passion led Asahi to pursue graduate studies at the esteemed Graduate School of Nippon Sport Science University, a leading institution recognized for producing top-tier sports professionals and researchers in Japan. During the formative academic years, Asahi honed critical thinking, empirical research skills, and a commitment to ethical scholarship, laying the foundation for a promising research-oriented career in sports and exercise psychology.

🏫 Professional Endeavors

Currently based at the Graduate School of Nippon Sport Science University, Asahi Matsubara is deeply engaged in both academic learning and empirical research. One of the key hallmarks of Asahi’s professional journey is the commitment to applying advanced psychological theories to real-world athletic settings. This includes investigating how leadership dynamics influence the behaviors and well-being of student-athletes—an area of study that has critical implications for both sports psychology and coaching practices in educational institutions.

In particular, Asahi’s recent work titled “Conditional process analysis of the impact of coach leadership on the voice of Japanese student-athletes”—published in the Asian Journal of Sport and Exercise Psychology (2025)—exemplifies a nuanced approach to understanding the psychological processes underlying athlete-coach interactions. The research not only reflects Asahi’s academic rigor but also emphasizes real-world relevance by focusing on the lived experiences of Japanese student-athletes. 📘

🔬 Contributions and Research Focus

Asahi Matsubara’s primary research focus lies at the intersection of leadership psychology, athlete behavior, and educational sports systems. With a keen interest in voice behavior, Asahi explores how athletes express their ideas, concerns, or feedback to coaches, and how leadership styles either foster or inhibit such behaviors. Using sophisticated methodologies like conditional process analysis, Asahi’s research illuminates the mediating and moderating variables that shape this dynamic.

The publication of the 2025 journal article in a Scopus-indexed journal serves as a critical milestone in this research journey. Moreover, Asahi’s scholarly contributions reflect a dedication to data-driven insights that can transform coaching models in educational and professional sports institutions alike.

Beyond publishing, Asahi is actively involved in academic collaborations and maintains an interest in interdisciplinary approaches to sport science. With a citation index that is steadily growing, Asahi is carving out a reputation as a rising scholar in the sport and exercise psychology research community. 📊

🏆 Accolades and Recognition

While still early in the professional journey, Asahi’s contributions have already begun to garner attention within academic circles. The nomination for the Best Researcher Award is a testament to the quality, originality, and impact of Asahi’s work. Recognition by peers and senior scholars is a significant milestone that affirms the value and relevance of Asahi’s contributions to the academic and sports communities.

Such acknowledgment is not only a personal achievement but also a motivator for continued excellence. It reinforces Asahi’s belief in the importance of scientific inquiry and its ability to create meaningful change in how we understand athletic performance and leadership. 🥇

🌏 Impact and Influence

Asahi Matsubara’s research goes beyond academic boundaries. By investigating psychological variables in coaching and athlete behavior, Asahi contributes to the development of healthier, more communicative, and empowered athletic environments. The implications of Asahi’s work extend to sports coaches, athletic trainers, school administrators, and policy-makers.

Student-athletes, especially in high-pressure academic contexts like Japan, benefit immensely from research that aims to enhance psychological safety and promote assertiveness. Through Asahi’s findings, institutions are better equipped to build trust-based relationships between coaches and athletes, ultimately leading to improved mental health and performance outcomes. 🌐

🌟 Legacy and Future Contributions

Looking ahead, Asahi Matsubara envisions a future filled with impactful contributions to the field of sport and exercise psychology. Plans are underway to expand current research themes into longitudinal studies, incorporating broader cultural variables and diverse athletic populations. Asahi is also eager to contribute to textbook development, academic teaching, and cross-institutional collaborations in Japan and internationally.

With a strong academic base, growing research portfolio, and commitment to social impact, Asahi aims to leave a legacy not just as a scholar, but as a transformational figure in educational sports systems. The long-term goal is to reshape coaching paradigms and champion athlete-centered practices that prioritize mental well-being and mutual respect. 🧭

Asahi Matsubara stands today not only as a researcher with promise but also as a symbol of the new generation of scholars—those who blend scientific excellence with societal relevance.

📝Notable Publications

Conditional process analysis of the impact of coach leadership on the voice of Japanese student-athletes

Author: Matsubara Asahi
Journal: Asian Journal of Sport and Exercise Psychology
Year: 2025

Prof. Dr. Xiaofeng Dai | Authentic Leadership | Best Researcher Award

Prof. Dr. Xiaofeng Dai | Authentic Leadership | Best Researcher Award

Xi’an Jiaotong University Medical College First Affiliated Hospital: The First Affiliated Hospital of Xi’an Jiaotong University, China

Author Profile

Scopus

Early Academic Pursuits 🎓

Dai Xiaofeng’s academic journey exemplifies a commitment to interdisciplinary research and innovation. His early studies took him to Tampere University of Technology, Finland, where he pursued a master’s degree in bioinformatics, and the Chinese Academy of Agricultural Sciences, where he earned a master’s degree in molecular biology. These foundational studies provided him with a solid background in computational and biological sciences, setting the stage for his later achievements. He further advanced his expertise by obtaining a Ph.D. in computational systems biology from Tampere University of Technology, focusing on genome-wide association studies (GWAS) and molecular mechanisms. Not content with a singular academic trajectory, he pursued a second Ph.D. in econometrics from Aalto University, Finland, where he applied computational biological methods to economic modeling. His doctoral education in genetics at the University of Helsinki added yet another layer to his multidisciplinary expertise.

Professional Endeavors and Research Focus 🔬

Following his extensive academic training, Dai Xiaofeng embarked on a research career that took him to the Finnish Center for Molecular Medicine and Helsinki Central Hospital, where he conducted postdoctoral research in GWAS and anti-cancer molecular mechanisms. These experiences allowed him to refine his expertise in genetic research and translational medicine. Upon his return to China, he established a pioneering research group at Xi’an Jiaotong University’s First Affiliated Hospital, focusing on the medical applications of Cold Atmospheric Pressure Plasma (CAP). His work in this domain has led to significant advancements in precision and translational medicine. He has investigated the multimodal anti-cancer molecular mechanisms of CAP and proposed a CAP redox balance model. His research also extends to the development of multi-dimensional anti-cancer tools, including the establishment of the first CAP database both domestically and internationally. He has played a crucial role in developing high-throughput, minimally invasive, and portable CAP medical devices, ensuring that these technologies can be effectively translated from research to real-world medical applications. His efforts to overcome technological barriers in CAP active preservation have further cemented his reputation as a leader in the field.

Contributions and Publications 📚

Dai Xiaofeng’s contributions to scientific literature are substantial. He has authored 104 SCI-indexed papers as the first and/or corresponding author, with his work appearing in top-tier journals such as Signal Transduction and Targeted Therapy, Redox Biology, Progress in Polymer Science, Biotechnology Advances, Advanced Science, Free Radical Biology and Medicine, Computational Biology and Medicine, Trends in Biotechnology, and Trends in Genetics. His research, spanning over 110 internationally published articles, has amassed a total impact factor of 746, highlighting the significance of his findings in both medical and engineering disciplines.

Accolades and Recognition 🏆

Dai Xiaofeng’s innovative research has earned him numerous accolades. His groundbreaking work in CAP translational medicine has been recognized through prestigious research grants and awards, both in China and internationally. His expertise has led to invitations to speak at global conferences on plasma medicine, molecular biology, and biomedical engineering. In addition to his academic honors, his collaborations with leading medical institutions and engineering firms have further reinforced the importance of his research. His contributions to national healthcare policies, particularly through his work on CAP-based therapeutic applications, demonstrate his influence beyond academia.

Impact and Influence 🌟

Dai Xiaofeng’s interdisciplinary research has had a profound impact on multiple fields. His work in CAP-based cancer treatment has introduced non-invasive therapeutic modalities, offering new hope to patients. His contributions to medical device innovation have led to the development of cutting-edge plasma-based tools, which are poised to revolutionize the treatment landscape. His emphasis on translational medicine ensures that groundbreaking research is not confined to laboratories but reaches the clinical setting, where it can benefit real patients. Beyond his own research, he has dedicated himself to mentoring young scientists, fostering a new generation of researchers capable of bridging multiple scientific disciplines.

Legacy and Future Contributions 🌐

Dai Xiaofeng’s legacy is one of innovation, interdisciplinary collaboration, and a relentless pursuit of scientific advancement. Looking ahead, he aims to expand CAP-based therapeutics into broader clinical applications, ensuring that these technologies become a staple in modern medical treatment. His future work will focus on the integration of artificial intelligence into CAP devices, optimizing their therapeutic potential. Strengthening collaborations between academia, industry, and healthcare providers remains a priority, as does advocating for policy changes that support the integration of CAP technology into mainstream medical practice. Through his pioneering research, Dai Xiaofeng continues to shape the future of biomedical science, leaving an indelible mark on the fields of medicine, engineering, and computational biology.

📝Notable Publications
  • Spermidine antagonizes the anti-cancer effect of cold atmospheric plasma and induces transit G0/G1 cell cycle arrest of triple negative breast cancers
    Authors: L. Shen, X. Lv, Y. Li, X. Dai
    Journal: Free Radical Biology and Medicine
    Year: 2025

  • Cold atmospheric plasma potentiates ferroptosis via EGFR(Y1068)-mediated dual axes on GPX4 among triple negative breast cancer cells
    Authors: X. Dai, Z. Xu, X. Lv, M. Xi, T. Li
    Journal: International Journal of Biological Sciences
    Year: 2025

  • Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation
    Authors: K. Zhu, Q. Lv, X. Lu, Y. Wang, X. Dai
    Journal: Free Radical Biology and Medicine
    Year: 2025

  • Metal-organic frameworks: potential synergies with cold atmospheric plasmas for cancer control
    Authors: X. Dai, Y. Yang
    Journal: Journal of Materials Chemistry B
    Year: 2024

  • Magnetic nanoparticles and possible synergies with cold atmospheric plasma for cancer treatment
    Authors: X. Dai, Y. Dai, Y. Zheng, Y. Lv
    Journal: RSC Advances
    Year: 2024